- Lobbying
- Lobbying by Association for Accessible Medicines
Lobbying Relationship
Bills mentioned
S.64: Preserve Access to Affordable Generics and Biosimilars Act
Sponsor: Amy Klobuchar (D-Minn.)
S.659: Biologic Patent Transparency Act
Sponsor: Susan Collins (R-Maine)
H.R.1506: FAIR Generics Act
Sponsor: Nanette Barragán (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Karin Hessler | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate